|
2014
|
Invention
|
Antifolate combinations.
The present invention provides combinations of active agents, such comb... |
|
2013
|
Invention
|
Method of droxidopa synthesis.
The present application relates to a novel method of preparing L-... |
|
|
Invention
|
Postural stability and incident functions in patients.
The present invention provides methods an... |
|
|
Invention
|
Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disor... |
|
2012
|
Invention
|
Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotensi... |
|
|
Invention
|
Anthranilic acid derivatives. 3. The compounds are useful for the treatment of autoimmune disease... |
|
|
Invention
|
Method of treating postural reflex abnormality caused by parkinson's disease. The present disclos... |
|
|
Invention
|
Threo-dops controlled release formulation. The present invention relates to pharmaceutical formul... |
|
2011
|
Invention
|
Combination comprising methotrexate and an antifolate compound. The present invention provides co... |
|
|
Invention
|
Antifolate combinations. The present invention provides combinations of active agents, such combi... |
|
|
Invention
|
Antifolate compositions. The present invention provides pharmaceutical compositions comprising an... |
|
|
Invention
|
Antifolate compositions.
The present invention provides pharmaceutical compositions comprising a... |
|
2010
|
Invention
|
Enzyme inhibiting compounds. The present invention is directed to compounds that are specifically... |
|
|
Invention
|
Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inf... |
|
|
Invention
|
Stable crystalline salts of antifolate compounds.
The present invention provides stable crystall... |
|
|
Invention
|
Stable crystalline polymorphs of the dipotassium salt of (s)-2-{4-[2-(2,4-diamino-quinazolin-6-yl... |
|
|
Invention
|
Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin... |
|
2009
|
Invention
|
Antifolate compositions. The present invention provides pharmaceutical compositions compris... |
|
|
Invention
|
Crystalline salt forms of antifolate compounds and methods of manufacturing thereof. The pr... |
|
|
Invention
|
Crystalline salt forms of antifolate compounds and methods of manufacturing thereof. The present ... |
|
|
Invention
|
Crystalline salt forms of antifolate compounds and methods of manufacturing thereof.
The present... |
|
2008
|
Invention
|
Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia. The present i... |
|
|
Invention
|
New compounds, methods for their preparation and use thereof. A compound of formula (I) wherein X... |
|
|
Invention
|
Substituted pyrrolo[2,3-d]pyrimidines as antifolates. The present invention is directed to antifo... |
|
|
Invention
|
New classical antifolates. The present invention is directed to antifolate compounds having the s... |
|
2007
|
Invention
|
Pharmaceutical compositions comprising droxidopa.
The present invention provides combinations of... |
|
|
Invention
|
Pharmaceutical compositions comprising droxidopa. The present invention provides combinations of ... |
|
2005
|
Invention
|
Quinazoline derivatives as metabolically inert antifolate compounds. The present invention... |
|
|
Invention
|
Quinazoline derivatives as metabolically inert antifolate compounds.. The present invention provi... |
|
|
Invention
|
Compounds, methods for their preparation and use thereof. Compounds of formula (I)
for clinical... |
|
2004
|
Invention
|
Compositions and methods for orthostatic intolerance.
The present invention relates to compositi... |
|
1998
|
Invention
|
Metabolically inert anti-inflammatory and anti-tumor antifolates. Hether to unknown metabolically... |
